Filing Details
- Accession Number:
- 0000899243-17-029061
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-18 17:48:05
- Reporting Period:
- 2017-12-15
- Accepted Time:
- 2017-12-18 17:48:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1560241 | G1 Therapeutics Inc. | GTHX | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1291884 | Medimmune Ventures, Inc. | C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Park Triangle NC 27709 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value Per Share | Disposition | 2017-12-15 | 200,000 | $19.75 | 2,950,630 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
